natus Echo-Screen III Pro - Echo-Screen III Technical Specifications; General Device and Power Specs

© 2020 Natus Medical Incorporated 41 026057 RevE
Technical Specifications Echo-Screen III Pro Instructions for Use
Technical Specifications
General
Device
Dimensions (L x W x H) 208.3 x 119.4 x 40.6 mm (8.2 x 4.7 x 1.6 in.)
Weight 453.6 g (16 oz.) excluding battery
576.1 g (20.32 oz.) including battery
Docking station
Dimensions (L x W x H) 245.1 x 121.9 x 76.2 mm (9.7 x 4.8 x 3.0 in.)
Weight 567 g (20 oz.)
Test modalities TEOAE, DPOAE, DPOAE+ and ABR
Patient storage capacity 300 patients
Test storage capacity 2000 test results
Power Battery powered with AC adapter (not for screening)
Display
Type TFT Color LCD
Screen size 10.9 cm (4.3 in.) diagonal
Resolution 480 x 272 pixels
Active area 95.0 x 53.9 mm (3.74 x 2.12 in.)
Backlight LED, dimmable
Touch screen Projected capacitive (works with or without gloves)
Touch screen construction Glass sensor plus cover glass, optically bonded
Touch input type Finger or minimum 7 mm (.28 in.) diameter conductive stylus
Keypad
Physical QWERTY style, 37-key alphanumeric, elastomeric keypad
Virtual On-screen QWERTY keyboard
Sound
Speaker Internal, user configurable for key clicks and user prompts
Real-Time Clock
Usage Time stamping test results
Synchronization Automatically synchronized with PC clock when docked
Backup Internal dedicated battery
Battery Rechargeable Li-ion coin, 3V, 11mAh, 9.5 mm diameter
Battery
Type Rechargeable Li-ion 3.65 V, 5300mAh (nominal)
Battery level indicator 5-step battery level indicator (on screen)
Max battery power consumption 1.8 W (while performing test)
Estimated battery life
1
Min. of 40 hearing screening tests or 16 hours continuous use
Certifications UN 38.3, UL1642, IEC 62133, Directive 2006/66/EC RoHS 2002/95/EC
Battery Charger
AC adapter 100-240 VAC, 50-60 Hz, 0.6A, OUTPUT: +5V, 3.0 A
Connector Barrel connector, 3.5 mm OD, 1.1 mm ID
Certification IEC 60601-1
Battery charge time 4.5 hours to 100%
AC Adapter Kit North America/Japan, Australia, UK, EU, Korea, Argentina, and China
1. Actual results may vary based on device configuration and screening modality.